Cargando…
Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma
Background: Liver hepatocellular carcinoma (LIHC) is a complicated disease with poor survival and lack of viable treatment options. The roles of ferroptosis and immunotherapy in LIHC are increasingly prominent, but the interplay of ferroptosis with the tumor microenvironment (TME) in LIHC is current...
Autores principales: | Liang, Yimin, Su, Shijie, Lun, Zhaoxia, Zhong, Zishao, Yu, Weifeng, He, Guihua, Wang, Qi, Wang, Jing, Huang, Suiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577028/ https://www.ncbi.nlm.nih.gov/pubmed/36267158 http://dx.doi.org/10.3389/fmolb.2022.1012505 |
Ejemplares similares
-
SLC7A11, a Potential Therapeutic Target Through Induced Ferroptosis in Colon Adenocarcinoma
por: Cheng, Xin, et al.
Publicado: (2022) -
Ferroptosis Regulator Modification Patterns and Tumor Microenvironment Immune Infiltration Characterization in Hepatocellular Carcinoma
por: Liu, Dong-Li, et al.
Publicado: (2022) -
INHBB is a novel prognostic biomarker and correlated with immune infiltrates in gastric cancer
por: Yu, Weifeng, et al.
Publicado: (2022) -
Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma
por: Li, Lanqing, et al.
Publicado: (2022) -
Ferroptosis-Related Gene Signature and Patterns of Immune Infiltration Predict the Overall Survival in Patients With Lung Adenocarcinoma
por: Wang, Yuxuan, et al.
Publicado: (2021)